MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr |
What is the latest Total Liabilities ratio of MANKIND PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹27,652 Cr |
| Mar2024 | ₹11,883 Cr |
| Mar2023 | ₹9,686 Cr |
| Mar2022 | ₹9,108 Cr |
| Mar2021 | ₹6,324 Cr |
How is Total Liabilities of MANKIND PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹27,652 Cr | 132.70 | |
| Mar2024 | ₹11,883 Cr | 22.68 | |
| Mar2023 | ₹9,686 Cr | 6.34 | |
| Mar2022 | ₹9,108 Cr | 44.04 | |
| Mar2021 | ₹6,324 Cr | - | |
Compare Total Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹94,120.5 Cr | 12.5% | 8.5% | -8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 12.5% |
8.5% |
-8.2% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses